Ajanta Pharma Ltd – Strategy, SWOT and Corporate Finance Report

Ajanta Pharma Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Ajanta Pharma Ltd (Ajanta Pharma) is a specialty pharmaceutical company, which focuses on the research, manufacture and commercialization of finished dosages in domestic and international markets. The company has a presence in cardiology, pain management, dermatology and ophthalmology therapy areas. It provides generics in developed markets of USA and branded generics in emerging countries such as India, Africa, CIS, Middle East and South East Asia. Ajanta Pharma also supplies multivitamins, eye drops, cough syrups and antibiotics to government bodies in India; and anti-malarial products to Africa and Global Fund. It operates subsidiaries in Mauritius, Philippines, Nigeria, the US and the UK. Ajanta Pharma is headquartered in Mumbai, Maharashtra, India.

Scope

Detailed information on Ajanta Pharma Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Ajanta Pharma Ltd in the form of a SWOT analysis

An in-depth view of the business model of Ajanta Pharma Ltd including a breakdown and examination of key business segments

News about Ajanta Pharma Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Ajanta Pharma Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Ajanta Pharma Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Ajanta Pharma Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Profic Organic Ltd

Oboi Laboratories Pvt Ltd

Biochem Pharmaceutical Industries Ltd

Aurobindo Pharma Ltd

Allied Chemicals and Pharmaceuticals Pvt Ltd

Alembic Pharmaceuticals Ltd

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Ajanta Pharma Ltd - Key Facts

Ajanta Pharma Ltd - Key Employees

Ajanta Pharma Ltd - Key Employee Biographies

Ajanta Pharma Ltd - Major Products and Services

Ajanta Pharma Ltd - History

Ajanta Pharma Ltd - Company Statement

Ajanta Pharma Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Ajanta Pharma Ltd - Business Description

Product Category: Africa Institution sale

Performance

Product Category: Emerging Market Generic Sales

Performance

Product Category: The US Generic Sales

Performance

R&D Overview

Ajanta Pharma Ltd - Corporate Strategy

Ajanta Pharma Ltd - SWOT Analysis

SWOT Analysis - Overview

Ajanta Pharma Ltd - Strengths

Ajanta Pharma Ltd - Weaknesses

Ajanta Pharma Ltd - Opportunities

Ajanta Pharma Ltd - Threats

Ajanta Pharma Ltd - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Recent Developments

Apr 03, 2019: Ajanta Pharma announces resignation of Dr. Anil Kumar as Independent Director of the Company

Jan 30, 2019: Ajanta Pharma reports Q3 FY 2019 consolidated result

Oct 31, 2018: Ajanta Pharma reports Q2 FY 2019 consolidated result

Aug 30, 2018: Ajanta Pharma announces resignation of director

Jul 31, 2018: Ajanta Pharma reports Q1 FY 2019 consolidated result

Jul 27, 2018: Ajanta Pharma: Update on US FDA inspection

May 02, 2018: Ajanta Pharma reports Q4 FY 2018 Consolidated Result

Jan 25, 2018: Ajanta Pharma: Q3 Income from Operations at Rs. 587 cr., PAT at Rs. 147 cr.

Jan 25, 2018: Ajanta Pharma reports Q3 FY 2018 Consolidated Result

Section 5 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Ajanta Pharma Ltd, Key Facts

Ajanta Pharma Ltd, Key Employees

Ajanta Pharma Ltd, Key Employee Biographies

Ajanta Pharma Ltd, Major Products and Services

Ajanta Pharma Ltd, History

Ajanta Pharma Ltd, Subsidiaries

Ajanta Pharma Ltd, Key Competitors

Ajanta Pharma Ltd, Ratios based on current share price

Ajanta Pharma Ltd, Annual Ratios

Ajanta Pharma Ltd, Annual Ratios (Cont…1)

Ajanta Pharma Ltd, Annual Ratios (Cont…2)

Ajanta Pharma Ltd, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Ajanta Pharma Ltd, Performance Chart (2015 – 2019)

Ajanta Pharma Ltd, Ratio Charts

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports